Mary Papaioannou

Primary treatment of multiple myeloma with thalidomide, vincristine, liposomal doxorubicin and dexamethasone(T-VAD doxil): a phase II multicenter study

Konstantinos Zervas, Meletios Α. Dimopoulos, E Hatzicharissi et al. · Annals of Oncology · 2003 · 118 citations · Full text

Hematological Malignancy, Medicine, Hematology +8

Minimal Residual Disease Tests Provide an Independent Predictor of Clinical Outcome in Adult Acute Lymphoblastic Leukemia

Forida Y. Mortuza, Mary Papaioannou, Ilidia M. Moreira et al. · Journal of Clinical Oncology · 2002 · 115 citations

Mrd Positivity, Molecular Markers, Mixed-phenotype Acute Leukemia +22

Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life‐threatening hemorrhage

Grigoris Gerotziafas, Costas Zervas, George Gavrielidis et al. · American Journal of Hematology · 2002 · 79 citations

Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukaemia reveals differences in treatment response

Letizia Foroni, LA Coyle, Mary Papaioannou et al. · Leukemia · 1997 · 75 citations

Hematological Malignancy, Lymphoid Neoplasia, Oncology +13

Deletion of 6q16-q21 in human lymphoid malignancies: a mapping and deletion analysis.

Adam Jackson, Paola Carrara, Veronique Duke et al. · PubMed · 2000 · 53 citations

Cytogenetics, Drosophila Tailless, Genetics +22